Five Prime Therapeutics
Latest round
- Series A
Last raised
- Apr 2012
Total raised
- $30M
Investors
- 11
About Five Prime Therapeutics
Based in California, US, and founded in 2001, Five Prime Therapeutics, Inc. develops immuno-oncology therapies intended for cancer patients. The company was founded by Lewis Williams and has offices located in San Francisco, US, Cambridge, US, Framingham, US, New York, US, and Seattle, US. In 2013, Five Prime Therapeutics, Inc., and in 2021, the company was acquired by Amgen Inc. Five Prime Therapeutics, Inc. develops therapeutics, under clinical trials, such as bemarituzumab - designed to block tumor growth causing cancer, FPT155 - stimulates anti-tumor immunity for solid tumors, FPA157 – helps enhance antibody-dependent cell-mediated cytotoxicity (ADCC) to eliminate cells causing cancer, and BMS-986258 (or TIM-3) – limits the duration and magnitude of cancer cells.
Who invested in Five Prime Therapeutics
11 investors across 3 rounds
See all investors in Five Prime Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Five Prime Therapeutics
Who invested in Five Prime Therapeutics?
Five Prime Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Five Prime Therapeutics raised?
Five Prime Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Five Prime Therapeutics last raise money?
Five Prime Therapeutics's most recent round on record is a Series A, in Apr 2012.
What does Five Prime Therapeutics do?
Based in California, US, and founded in 2001, Five Prime Therapeutics, Inc.
Where is Five Prime Therapeutics headquartered?
Five Prime Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Five Prime Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Five Prime Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Five Prime Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.